Chardan Capital Reiterates Rating on CAMP $CAMP
Key Points
- Chardan Capital now rates CAMP4 THERAPEUTICS CORPORATION ($CAMP) "buy" with a $6.50 target.
- Chardan Capital's $6.50 price target implies 55.13% upside from CAMP4 THERAPEUTICS CORPORATION's ($CAMP) current $4.19 share price.
- The Street's average $CAMP price target is $9.92 (Strong Buy).
- $CAMP last traded around $4.19.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Chardan Capital reiterated its rating on CAMP4 THERAPEUTICS CORPORATION ($CAMP) to a "buy" rating in a recent research note and set a price target of $6.50, a 55.13% upside from the current price.
CAMP4 THERAPEUTICS CORPORATION Stock Up 1.0%
Shares of CAMP4 THERAPEUTICS CORPORATION ($CAMP) traded around $4.19 on Saturday, up 1.0% for the day.
CAMP4 THERAPEUTICS CORPORATION Earnings
Analysts Set New Price Targets
About CAMP4 THERAPEUTICS CORPORATION
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Get CAMP4 THERAPEUTICS CORPORATION alerts
New 13F filings, insider trades, and analyst moves on $CAMP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.